Table 4.
Catalytic efficiencies of BdPTE mutants towards V-type nerve agents
| kcat/KM (× 106 M−1 min−1) | BdPTE-1 | BdPTE-2b | BdPTE-3 | BdPTE-4 | BdPTE-5b | BdPTE-6 | BdPTE-7 |
|---|---|---|---|---|---|---|---|
| V1 | 26.40 ± 0.24 | 146 ± 4.01 | 69.4 ± 1.56 | 49.9 ± 1.56 | 26.90 ± 0.45 | 17.20 ± 0.20 | 38.10 ± 0.36 |
| V2 | 14.9 ± 0.39 | 87.6 ± 3.68 | 38.2 ± 0.51 | 23.6 ± 0.26 | 14.50 ± 0.12 | 9.94 ± 0.16 | 12.80 ± 0.11 |
| V3 | 4.21 ± 0.17 | 16.1 ± 0.03 | 5.26 ± 0.50 | 3.05 ± 0.03 | 3.12 ± 0.09 | 2.17 ± 0.08 | 4.33 ± 0.14 |
| V4 (VX) | 11.30 ± 0.35 | 45.9 ± 0.76a | 63.1 ± 0.24a | 38.1 ± 0.36 | 11.80 ± 0.17 | 16.80 ± 0.47 | 20.70 ± 0.48 |
| V5 | 4.41 ± 0.06 | 10.2 ± 0.03 | 5.43 ± 0.18 | 5.21 ± 0.11 | 1.71 ± 0.02 | 1.57 ± 0.07 | 3.45 ± 0.02 |
| V6 | 5.61 ± 0.43 | 28.3 ± 0.34 | 21.8 ± 0.84 | 16.1 ± 0.04 | 4.74 ± 0.55 | 4.24 ± 0.05 | 9.62 ± 0.39 |
| V7 | 2.74 ± 0.10 | 5.69 ± 0.03 | 2.73 ± 0.13 | 3.58 ± 0.03 | 1.18 ± 0.02 | 1.44 ± 0.04 | 4.03 ± 0.11 |
| V8 (VR) | 1.03 ± 0.004 | 5.68 ± 0.07 | 6.06 ± 0.05a | 5.89 ± 0.26 | 21.40 ± 0.14 | 26.20 ± 0.98 | 22.20 ± 0.66 |
| V9 (CVX) | 2.00 ± 0.06 | 5.98 ± 0.19 | 6.49 ± 0.22 | 5.24 ± 0.24 | 10.60 ± 0.22 | 11.10 ± 0.34 | 9.60 ± 0.22 |
| V10 | 0.30 ± 0.01 | 0.64 ± 0.01 | 0.66 ± 0.06 | 0.56 ± 0.01 | 2.01 ± 0.003 | 0.33 ± 0.006 | 0.90 ± 0.03 |